Cancer Investigation

Cancer Investigation is published by Informa Healthcare and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer Treatment and Pharmacology, Lung Cancer Treatments and Mutations and Colorectal Cancer Treatments and Studies, together about 19.6% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)

Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology. It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section. One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology. Edited by leading physicians and research scientists, these sections make Cancer Investigation the prime resource for clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field. In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic.

Source: LetPub

Research area (LetPub): Oncology

CAS Journal Ranking

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Impact

Impact factor

2.43LetPub · 2026-09-13

CiteScore 2026-06

3.7LetPub · 2026-09-13

SJR 2026-06

0.5LetPub · 2026-09-13

SNIP 2026-06

0.42LetPub · 2026-09-13

h-index

77LetPub · 2026-09-13

h-index

115OpenAlex · 2026-10-01

i10-index

2,060OpenAlex · 2026-10-01

2-year mean citedness

2.05OpenAlex · 2026-10-01

Self-citation rate

4.5%LetPub · 2026-09-13

Share of gold OA articles

6.7%LetPub · 2026-09-13

Volume

Articles per year

87LetPub · 2026-09-13

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Other sources

Average review time (community reports)

about 8.5 monthsLetPub · 2026-09-13

Average acceptance (community reports)

50%LetPub · 2026-09-13

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

No source has fee information yet; check the journal's website.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Publisher

Informa Healthcare

Country or region

UNITED STATES

Language

English

Frequency

Bimonthly

Founded

1983

ISSN

0735-7907

Electronic ISSN

1532-4192

Official links

• Journal homepage ↗OpenAlex
• Submission system ↗LetPub